Thai clinics primarily use Mesenchymal Stem Cells (MSCs) sourced from the umbilical cord, bone marrow, and adipose tissue. Providers specialise in allogeneic umbilical cord-derived MSCs for systemic rejuvenation and autologous bone marrow or fat-derived cells for targeted orthopaedic and aesthetic repairs.
- Umbilical cord-derived MSCs: Sourced from Wharton’s jelly for systemic anti-aging and immune support.
- Bone marrow-derived cells: Primarily used for orthopedic treatments like knee osteoarthritis and joint repair.
- Adipose-derived cells: Harvested from patient fat for aesthetic treatments and skin rejuvenation.
- Acellular exosomes: Extracellular vesicles used for hair loss and rapid cellular signaling treatments.
- Placenta-derived products: Utilised for tissue renewal, vascular repair, and reducing systemic inflammation.
Bookimed Expert Insight: Thai clinics often specialise by cell source and concentration. For example, Dr. Theeracha Wuttiphan at ID Clinic Bangkok trained in Melbourne, bringing Australian-standard expertise to local MSC therapy. Patients can choose precise doses, such as 80 million MSCs, specifically for joint or systemic healing.
Patient Consensus: Patients find the process in Thailand runs smoothly, especially for anti-aging and wound care. Many value the choice between donor-derived umbilical cells and their own autologous cells. Verified cell counts and clear protocols give Australian patients confidence in the clinical treatments.